Hans Peter Grimm, Vanessa Schumacher, Martin Schäfer, Sabine Imhof-Jung, Per-Ola Freskgård, Kevin Brady, . . . Niels Janssen. (2023). Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans. Taylor & Francis Group.
Chicago Style (17th ed.) CitationHans Peter Grimm, et al. Delivery of the Brainshuttle™ Amyloid-beta Antibody Fusion Trontinemab to Non-human Primate Brain and Projected Efficacious Dose Regimens in Humans. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationHans Peter Grimm, et al. Delivery of the Brainshuttle™ Amyloid-beta Antibody Fusion Trontinemab to Non-human Primate Brain and Projected Efficacious Dose Regimens in Humans. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.